Publicaciones en las que colabora con JOSÉ MARÍA AGUADO GARCÍA (23)

2022

  1. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID

    Biomedicines, Vol. 9, Núm. 11

  2. Alterations in circulating monocytes predict covid-19 severity and include chromatin modifications still detectable six months after recovery

    Biomedicines, Vol. 9, Núm. 9

  3. Circulatory follicular helper T lymphocytes associate with lower incidence of CMV infection in kidney transplant recipients

    American Journal of Transplantation, Vol. 21, Núm. 12, pp. 3946-3957

  4. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  5. Discordance Between SARS-CoV-2-specific Cell-mediated and Antibody Responses Elicited by mRNA-1273 Vaccine in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 7, Núm. 12, pp. E794

  6. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  7. IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 5, pp. 1652-1661.e1

  8. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12

  9. SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1258-1262

  10. T cell–mediated response to SARS-CoV-2 in liver transplant recipients with prior COVID-19

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2785-2794